A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced FDA approval for an update to its Varipulse platform's irrigation flow ...

Johnson & Johnson (JNJ) said on Tuesday that it has submitted a supplemental new drug application to the U.S. Food and Drug ...

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

The US Food and Drug Administration has not approved rapamycin for anti-aging therapy, but physicians have been prescribing it off-label because it has been shown to extend the healthy lifespan of ...

FDA issued an Early Alert for Abiomed's Automated Impella Controllers due to potential safety concerns following reports of 3 ...

A massive analysis recently published in the journal Aging Cell revealed that rapamycin — the immunosuppressant drug turned ...

Bread sold in a dozen states, including Ohio, has been recalled because the product may contain undeclared hazelnuts, ...

The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...

The Food and Drug Administration has approved Johnson & Johnson’s Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis, a chronic disease of the ...

The proposal from the Food and Drug Administration and mandated by Congress is intended to reassure consumers about the safety of makeup, baby powder and other personal care products.

A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who ...